Taiyen Biotech Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 790.085 million compared to TWD 724.457 million a year ago. Operating income was TWD 129.449 million compared to TWD 96.894 million a year ago. Net income was TWD 102.563 million compared to TWD 65.850 million a year ago. Basic earnings per share from continuing operations was TWD 0.51 compared to TWD 0.33 a year ago.